COVID-19 pandemic witnessed rapid development and use of several vaccines. In India, a
country-wide immunization was initiated in January 2021. COVISHIELD, the chimpanzee …

Patients with chronic lymphocytic leukemia (CLL) treated with B-cell pathway inhibitors and
anti-CD20 antibodies exhibit low humoral response rates following SARS-CoV-2 …

The development of vaccines has drastically reduced the mortality and morbidity of several
diseases. Despite the great success of vaccines, the immunological processes involved in …

The widely used ChAdOx1 nCoV-19 (ChAd) vector and BNT162b2 (BNT) mRNA vaccines
have been shown to induce robust immune responses. Recent studies demonstrated that …

Protein three-dimensional structural analysis using artificial intelligence is attracting
attention in various fields, such as the estimation of vaccine structure and stability. In …

Background To cope with the persistence of the COVID-19 epidemic and the decrease in
antibody levels following vaccination, a third dose of vaccine has been recommended in the …

The Omicron variant is the most divergent, displaying more mutations than previous SARS-
CoV-2 variants, particularly in the gene that encodes the spike protein. This study aimed to …

Evidence has suggested an increased risk of psychiatric manifestations following viral
infections including coronavirus disease-2019 (COVID-19). However, psychiatric adverse …

The understanding of dynamic plasma proteome features in hybrid immunity and
breakthrough infection is limited. A deeper understanding of the immune differences …

Heterologous boost regimens are being increasingly considered against SARS-CoV-2. We
report results for the 32 of 45 participants in the Phase 1 CoV2-001 clinical trial (Kim et al …